Kezar Life Sciences
55 hedge funds and large institutions have $36.8M invested in Kezar Life Sciences in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.13% less ownership
Funds ownership: 4.92% → 4.79% (-0.13%)
Holders
55
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.28M | |
| 2 | +$1.28M | |
| 3 | +$468K | |
| 4 |
RC
RBF Capital
San Francisco,
California
|
+$359K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$276K |
Top Sellers
| 1 | -$3.04M | |
| 2 | -$1.51M | |
| 3 | -$161K | |
| 4 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$147K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$139K |